Home » Topics » BioWorld Science

BioWorld Science
RSS

Yoshitomi and Yamasa Shoyu out-license DMDC

July 12, 1996

Positive safety, efficacy profile of HMG-CoA reductase inhibitors in hyperlipidemia treatment

July 12, 1996

ICOS issued U.S. patent relating to ICAM-3

July 12, 1996

TCV-309: Potential agent for transplantation of ischemically injured kidney

July 12, 1996

GT32-B: a novel antibacterial/antitumor immunosuppresant

July 12, 1996

Sankyo reveals potential immunosupressants

July 12, 1996

Ciba-Geigy identifies antiinflammation agents

July 12, 1996

Immunosuppressive and antiinflammatory agents from Italfarmaco

July 12, 1996

SB-210313: A potent LPS-TNF production inhibitor

July 12, 1996

Antiinflammatory bone resorption inhibitors from Takeda

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...